Percutaneous Coronary Intervention | Radiocontrast Media Induced Hyponatremia
Percutaneous Coronary Intervention research study
What is the primary objective of this study?
Osmolality of contrast media can be resulted in translocational hyponatremia after
percutaneous coronary intervention.
Who is eligible to participate?
- Patients who receive contrast media during percutaneous coronary intervention
- Patients who have sensitivity to contrast media.
- Liver cirrhosis
- Patients who receive IVIG or mannitol.
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Percutaneous Coronary Intervention
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
GFR >= 60MDRD eGFR 60 or more
GFR <60Under MDRD eGFR 60
Start Date: October 2010
Completed Date: June 2011
Primary Outcome: Incidence of contrast media induced translocational hyponatremia
Secondary Outcome: Renal function is affected by the incidence of translocational hyponatremia.
Study sponsors, principal investigator, and references
Principal Investigator: Sejoong Kim, MD, PhD
Lead Sponsor: Gachon University Gil Medical Center
Aronson D, Dragu RE, Nakhoul F, Hir J, Miller A, Boulos M, Zinder O, Green J, Mittleman MA, Markiewicz W. Hyponatremia as a complication of cardiac catheterization: a prospective study. Am J Kidney Dis. 2002 Nov;40(5):940-6.